|[August 15, 2014]
Shapiro Haber & Urmy LLP Announces It Filed the Securities Fraud Class Action Lawsuit Against InVivo Therapeutics Holdings Corp.
BOSTON --(Business Wire)--
The Boston, MA law firm Shapiro Haber & Urmy LLP filed the class action
securities fraud suit against InVivo Therapeutics Holdings Corp.
("InVivo")(OTCBB: NVIV), a Cambridge, MA company, and its former
Chairman and CEO for violations of federal securities laws on July 31,
2014. The firm filed the complaint in the United States District Court
for the District of Massachusetts, entitled Battle Construction Co.,
Inc. v. InVivo Therapeutics Holdings Corp., et al., C.A. No.
Shapiro Haber & Urmy LLP conducted a careful investigation before filing
its Complaint, which alleges that the Defendants made false and
misleading statements about the FDA's approval of a clinical trial and
the time for completion of the trial and submission of data to the FDA.
The Complaint alleges that these misstatements andomissions by
Defendants misrepresented and/or omitted material facts to the investing
public, in violation of Sections 10(b) and 20(a) of the Securities
The class action is brought on behalf of all persons and entities who
purchased common stock of InVivo during the period from April 5, 2013
through August 26, 2013.
If you would like more information about this case, you are interested
in joining the suit, or you wish to register with the firm as a member
of the class, please contact the firm at the telephone numbers below or
The factual and legal bases for the Plaintiff's claims are set forth in
greater detail in the Complaint, which is available at www.shulaw.com.
More information about the law firm and its qualifications is available
Several other law firms have published notices announcing the filing of
a law suit against InVivo.
Shapiro Haber & Urmy LLP is the only firm that has investigated the
company and has actually filed a complaint.
[ Back To Technology News's Homepage ]